| HOME >> BIOLOGY >> TECHNOLOGY |
Total Current Assets 38,830,343 25,707,128
Non-current Assets:
Property and equipment, net of
accumulated depreciation of
$1,003,802 and $619,645,
respectively 2,625,216 2,725,173
Intangible assets, net of
accumulated amortization of
$221,715 and $135,656, respectively 2,063,252 65,344
Deferred tax assets 187,509 16,736
Total Non-current Assets 4,875,977 2,807,253
TOTAL ASSETS $43,706,320 $28,514,381
LIABILITIES AND SHAREHOLDERS'
EQUITY
Current Liabilities:
Trade accounts payable $ 297,299 $ 477,291
Accrued expenses 261,301 104,216
Accrued taxes payable 311,009 167,419
Other payables 86,161 185,096
Advances from customers 261,583 141,871
Accounts payable - related parties -- 22,650
Short-term notes payable 2,693,428 6,533,649
Total Current Liabilities 3,910,781 7,632,192
Research and development
commitments 34,181 31,980
Total Liabilities 3,944,962 7,664,172
Stockholders' Equity:
Common stock, $0.001 par value,
60,000,000 shares authorized,
37,278,938 and 34,723,056
shares issued and
outstanding, respectively 37,279 34,723
Additional paid-in capital 11,678,606 7,764,979
Foreign currency translation
adj
'/>"/>
| SOURCE China Pharma Holdings, Inc. Copyright©2008 PR Newswire. All rights reserved |